(Q41093072)

26 September 2017

1 reference

title

Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs (English)

1 reference

26 September 2017

R Fisher

1

1 reference

PubMed ID

8784219

26 September 2017

D Blum

series ordinal

2

1 reference

26 September 2017

1 January 1995

1 reference

26 September 2017

1 reference

26 September 2017

36 Suppl 2

1 reference

26 September 2017

S105-14

1 reference

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

26 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

In vivo studies on the mechanism of action of the broad spectrum anticonvulsant loreclezole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Memory and psychomotor effects of oxcarbazepine in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Comparison of the effects of carbamazepine and oxcarbazepine on peripheral nerve conduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

N-methyl aspartate activates voltage-dependent calcium conductance in rat hippocampal pyramidal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Stiripentol in atypical absence seizures in children: an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Ictal bradycardia with syncope: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Epilepsy and driving: an international perspective. Joint Commission on Drivers' Licensing of the International Bureau for Epilepsy and the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Anticonvulsant and sodium channel blocking effects of ralitoline in different screening models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Efficacy and safety of zonisamide: results of a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Loreclezole monotherapy in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Ralitoline (CI-946) and CI-953 block sustained repetitive sodium action potentials in cultured mouse spinal cord neurons and displace batrachotoxinin A 20-α-benzoate binding in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Comparison of the effect of the GABA uptake blockers, tiagabine and nipecotic acid, on inhibitory synaptic efficacy in hippocampal CA1 neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Progabide for previously untreated absence epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Hyponatremic coma under oxcarbazepine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

Respiratory and sedative effects of clobazam and clonazepam in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1995.TB05993.X

10.1111/J.1528-1157.1995.TB05993.X

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8784219